Facebook Linkedin RSS Twitter Youtube
Home 2024

Ethics, law and policy

Modeling Clonal Evolution in Hematopoietic Malignancies
Cancer

Modeling Clonal Evolution in Hematopoietic Malignancies

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

Techno-Economic Analyses Link Process Parameters to Financial Metrics
Bioprocessing

Techno-Economic Analyses Link Process Parameters to Financial Metrics

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s
Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Rethinking Pharma and Biotech Outsourcing
BioPerspectives

Rethinking Pharma and Biotech Outsourcing

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback
Drug Discovery

StockWatch: Chinese Biotechs Targeted by BIOSECURE Act Rise after House Committee Setback

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases
Bioprocessing

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

123...114Page 1 of 114
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.